Streetbeat News

Stock Prices

MYNZ

Mainz Biomed announced positive topline results from its ColoFuture study, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 12:30 pm

SPY

The Consumer Price Index (CPI) for August has come in at 3.7%, slightly above the estimated 3.6%.

Portfolio Pulse from Bill Haddad

September 13, 2023 | 12:30 pm

WKHS

Workhorse Group Inc. has received IRS approval as a qualified manufacturer for the Commercial Clean Vehicle Credit, which has led to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 12:29 pm

ORCL

Oracle Corporation (NYSE:ORCL) shares traded lower after mixed first-quarter financial results. The company reported a revenue of $12.45 billion, up 9% year-over-year, slightly below the market estimate of $12.46 billion. Adjusted earnings per share of $1.19 beat the consensus estimate of $1.15. Oracle's stock is expected to move lower through the September expiration.

Portfolio Pulse from Lisa Levin

September 13, 2023 | 12:28 pm

HOTH

Hoth Therapeutics announced that its new molecular entity, HT-KIT, has been successful in killing cancer cells in gastrointestinal stromal tumors and acute myeloid leukemia. This has led to an increase in the company's share prices.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 12:28 pm

SQFT

Trading of Presidio Property Trust shares has been halted due to pending news.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 12:26 pm

EIGR

Eiger BioPharmaceuticals has decided to discontinue its Phase 3 LIMT-2 study of peginterferon lambda in patients with chronic hepatitis delta, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 12:24 pm

HOTH

Hoth Therapeutics has announced that its new molecular entity, HT-KIT, has shown promising results in preclinical studies for systemic mastocytosis. The drug has demonstrated the ability to kill cancer cells in both gastrointestinal stromal tumors and acute myeloid leukemia.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 12:20 pm

KULR

KULR Technology has announced a proposed public offering of common stock, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 12:20 pm

REVG

REV Group reported better-than-expected Q3 financial results and raised its FY23 net sales guidance above estimates, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 12:19 pm